Samsara Therapeutics, Inc. is biopharmaceutical company aiming to discover first-in-class therapeutics that treat rare genetic and neurodegenerative disease, and extend healthy lifespan. Samsara's platform is the largest ever pipeline for the identification, chemical optimization, and in vivo validation of compounds that enhance autophagy. Samsara Therapeutics is a global biotech company with operations in Oxford and Boston and significant academic collaborations in Paris and Graz
Member count: 11-50
Total raised: $3.2M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Apollo Ven... | apollo.vc |
| - | Korify Cap... | korifycapi... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 21.12.2019 | Seed | $3.2M | - | - |